Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
1.94
↓ 86% below average
Average (9y)
14.01
Historical baseline
Range
High:32.96
Low:1.19
CAGR
-16.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.94 | +63.0% |
| 2023 | 1.19 | -74.1% |
| 2022 | 4.59 | -81.1% |
| 2021 | 24.30 | +22.4% |
| 2020 | 19.85 | -39.8% |
| 2019 | 32.96 | +564.4% |
| 2018 | 4.96 | -83.6% |
| 2017 | 30.27 | +192.4% |
| 2016 | 10.35 | +7.0% |
| 2015 | 9.67 | - |